Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ImaginAb closes $12.5mm Series A round

Executive Summary

ImaginAb Inc. (developing in vivo imaging agents for cancer and autoimmune diseases) has raised $12.5mm in its oversubscribed Series A financing led by Novartis Venture Funds, which was joined by Merieux Developpement, Nextech Invest, Cycad Group, an undisclosed backer, and returning seed investor Momentum Biosciences. Representatives from Novartis Venture Funds and Merieux Developpement will join the board.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies